These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 14756369)

  • 1. Collagenase-1 (MMP-1) activity in equine synovial fluid: influence of age, joint pathology, exercise and repeated arthrocentesis.
    Brama PA; van den Boom R; DeGroott J; Kiers GH; van Weeren PR
    Equine Vet J; 2004 Jan; 36(1):34-40. PubMed ID: 14756369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of repeated arthrocentesis and exercise on matrix metalloproteinase and tumour necrosis factor alpha activities in normal equine joints.
    van den Boom R; Brama PA; Kiers GH; DeGroot J; Barneveld A; van Weeren RR
    Equine Vet J; 2004 Mar; 36(2):155-9. PubMed ID: 15038439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of development and joint pathology on stromelysin enzyme activity in equine synovial fluid.
    Brama PA; TeKoppele JM; Beekman B; van El B; Barneveld A; van Weeren PR
    Ann Rheum Dis; 2000 Feb; 59(2):155-7. PubMed ID: 10666176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of repeated arthrocentesis and exercise on synovial fluid concentrations of nitric oxide, prostaglandin E2 and glycosaminoglycans in healthy equine joints.
    van den Boom R; van de Lest CH; Bull S; Brama RA; van Weeren PR; Barneveld A
    Equine Vet J; 2005 May; 37(3):250-6. PubMed ID: 15892235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase activity in equine synovial fluid: influence of age, osteoarthritis, and osteochondrosis.
    Brama PA; TeKoppele JM; Beekman B; van Weeren PR; Barneveld A
    Ann Rheum Dis; 1998 Nov; 57(11):697-9. PubMed ID: 9924215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between synovial fluid levels of glycosaminoglycans, hydroxyproline and general MMP activity and the presence and severity of articular cartilage change on the proximal articular surface of P1.
    van den Boom R; van der Harst MR; Brommer H; Brama PA; Barneveld A; van Weeren PR; DeGroot J
    Equine Vet J; 2005 Jan; 37(1):19-25. PubMed ID: 15651729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of MMP-2 and -9 activities in synovial fluid of horses with osteoarthritic and arthritic joint diseases using gelatin zymography and immunocapture activity assays.
    Fietz S; Einspanier R; Hoppner S; Hertsch B; Bondzio A
    Equine Vet J; 2008 May; 40(3):266-71. PubMed ID: 18089467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in synovial fluid and serum biomarkers with exercise and early osteoarthritis in horses.
    Frisbie DD; Al-Sobayil F; Billinghurst RC; Kawcak CE; McIlwraith CW
    Osteoarthritis Cartilage; 2008 Oct; 16(10):1196-204. PubMed ID: 18442931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases 2 and 9 in equine synovial fluids.
    Clegg PD; Coughlan AR; Riggs CM; Carter SD
    Equine Vet J; 1997 Sep; 29(5):343-8. PubMed ID: 9306059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synovial fluid gelatinase concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses.
    Trumble TN; Trotter GW; Oxford JR; McIlwraith CW; Cammarata S; Goodnight JL; Billinghurst RC; Frisbie DD
    Am J Vet Res; 2001 Sep; 62(9):1467-77. PubMed ID: 11560279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metalloproteinases and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with articular cartilage alterations.
    Jouglin M; Robert C; Valette JP; Gavard F; Quintin-Colonna F; Denoix JM
    Vet Res; 2000; 31(5):507-15. PubMed ID: 11050746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gambling on putative biomarkers of osteoarthritis and osteochondrosis by equine synovial fluid proteomics.
    Chiaradia E; Pepe M; Tartaglia M; Scoppetta F; D'Ambrosio C; Renzone G; Avellini L; Moriconi F; Gaiti A; Bertuglia A; Beccati F; Scaloni A
    J Proteomics; 2012 Jul; 75(14):4478-93. PubMed ID: 22361695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the effects of age and joint disease on hydroxyproline and glycosaminoglycan concentrations in synovial fluid from the metacarpophalangeal joint of horses.
    van den Boom R; Brama PA; Kiers GH; de Groot J; van Weeren PR
    Am J Vet Res; 2004 Mar; 65(3):296-302. PubMed ID: 15027675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid.
    Srinivas R; Sorsa T; Tjäderhane L; Niemi E; Raustia A; Pernu H; Teronen O; Salo T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):517-25. PubMed ID: 11346728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
    Ahrens D; Koch AE; Pope RM; Stein-Picarella M; Niedbala MJ
    Arthritis Rheum; 1996 Sep; 39(9):1576-87. PubMed ID: 8814070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sandwich ELISA system for cartilage oligomeric matrix protein in equine synovial fluid and serum.
    Yamanokuchi K; Tagami M; Nishimatsu E; Shimizu Y; Hirose Y; Komatsu K; Misumi K
    Equine Vet J; 2009 Jan; 41(1):41-6. PubMed ID: 19301580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
    Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of cartilage oligomeric matrix protein (COMP) degradation and synthesis in equine joint disease.
    Arai K; Misumi K; Carter SD; Shinbara S; Fujiki M; Sakamoto H
    Equine Vet J; 2005 Jan; 37(1):31-6. PubMed ID: 15651731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase protein expression profiles cannot distinguish between normal and early osteoarthritic synovial fluid.
    Heard BJ; Martin L; Rattner JB; Frank CB; Hart DA; Krawetz R
    BMC Musculoskelet Disord; 2012 Jul; 13():126. PubMed ID: 22824140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
    J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.